CLX-EX

N/A

Report date: 2023/07/10 17:58:48
NMEFirst In Class

Base Information

Drug NameCLX-EX
Drug Alias NameCLX-EX
ClassificationSmall molecules
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCytosinLab Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A